| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 12/07/2011 | EP1141248B1 A method for the high level expression of the active form of lymphotoxin-beta receptor immunoglobulin fusion proteins and their purification |
| 12/07/2011 | CN102272606A 兔因子Ⅶ的分离肽 Rabbit isolated peptide factor Ⅶ |
| 12/07/2011 | CN102272306A 抗-Siglec-15抗体 Anti -Siglec-15 antibody |
| 12/07/2011 | CN102272161A 免疫原性降低的工程抗体与制备方法 Reduced immunogenicity of engineered antibody production method |
| 12/07/2011 | CN102272160A 抗rhd单克隆抗体 Monoclonal antibody anti rhd |
| 12/07/2011 | CN102272159A 结合SPARC的ScFc Combination of SPARC ScFc |
| 12/07/2011 | CN102272158A 源自记忆b细胞的人单克隆抗体的快速表达克隆 Memory cells derived from human monoclonal antibodies b Rapid expression cloning |
| 12/07/2011 | CN102272157A 用于抑制cripto/grp78复合物形成和信号的组合物和方法 Compositions and methods for inhibiting cripto / grp78 complex formation and signals |
| 12/07/2011 | CN102272156A 通过调控膜联蛋白-1对自身免疫疾病的治疗 Through the regulation of annexin -1 treatment of autoimmune diseases |
| 12/07/2011 | CN102272155A 登革热病毒中和抗体及其用途 Dengue virus neutralizing antibodies and uses thereof |
| 12/07/2011 | CN102272154A 单域抗原结合性分子的纯化方法 Purification of the single domain antigen-binding molecule |
| 12/07/2011 | CN102272151A Crhr2肽激动剂及其用途 Crhr2 peptide agonists and their uses |
| 12/07/2011 | CN102272146A 用带负电的聚合物沉淀生物分子 With a negatively charged polymer precipitated biomolecule |
| 12/07/2011 | CN102272145A 亲和色谱基质 Affinity chromatography matrix |
| 12/07/2011 | CN102272144A 采用单一聚合物相系统的分离方法 Polymer phase separation method using a single system |
| 12/07/2011 | CN102271710A 用于治疗动脉粥样硬化的b细胞耗竭剂 For the treatment of atherosclerosis in b-cell depleting agent |
| 12/07/2011 | CN102271708A Cd37免疫治疗联合疗法及其用途 Cd37 immunotherapy and its use in combination therapy |
| 12/07/2011 | CN102271703A 用于治疗补体相关障碍的方法和组合物 For the treatment of complement-associated disorders The methods and compositions |
| 12/07/2011 | CN102268409A Monoclonal antibody against human protein RN181 and hybridoma cell strain 3952 and kit |
| 12/07/2011 | CN102268408A 分泌抗β-内酰胺酶单克隆抗体杂交瘤细胞株及其制备方法 Secretory anti-β- lactamase monoclonal antibody hybridoma cell line and its preparation method |
| 12/07/2011 | CN102268091A 一种能识别草鱼IgM的单链抗体C1B3 One kind of grass carp IgM can identify single-chain antibody C1B3 |
| 12/07/2011 | CN102268090A 一种暹罗鳄血液提取物及其提取方法和用途 One kind of Siamese crocodile blood extract and extraction methods and uses |
| 12/07/2011 | CN102268089A Agr2阻断抗体及其用途 Agr2 blocking antibodies and uses thereof |
| 12/07/2011 | CN102268088A 一种用于生产大菱鲆免疫球蛋白的方法 A production of turbot method for immunoglobulin |
| 12/07/2011 | CN102268087A 针对狂犬病病毒核蛋白保守线性表位肽的单抗的制备方法 For the preparation of monoclonal rabies virus nucleoprotein conserved linear epitope peptide |
| 12/07/2011 | CN102268086A 鸡同源特异性血清和免疫球蛋白的制备与应用 Preparation and application of specific serum and chicken homologous immunoglobulin |
| 12/07/2011 | CN101967465B 视黄醇结合蛋白单抗、其杂交瘤细胞及其制备方法和用途 Retinol binding protein monoclonal antibody hybridoma preparation method and its use |
| 12/07/2011 | CN101696234B 抗类风湿性关节炎的多肽及其在制药中的应用 Anti-rheumatoid arthritis peptide and its application in pharmacy |
| 12/07/2011 | CN101407544B 抗高尔基体蛋白单克隆抗体及应用 Anti-Golgi protein monoclonal antibody and application |
| 12/07/2011 | CN101121021B 人源化抗ErbB2抗体及用抗ErbB2抗体进行的治疗 Humanized anti-ErbB2 antibody treatment with anti-ErbB2 antibody and carried out |
| 12/06/2011 | US8071745 Polynucleotides encoding rod-derived cone viability factor (rdcvf) and methods of using the same |
| 12/06/2011 | US8071743 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
| 12/06/2011 | US8071733 Antibodies that specifically bind hedgehog-derived polypeptides |
| 12/06/2011 | US8071731 Antibodies to myelin associated glycoprotein (MAG); neurological diseases/disorders |
| 12/06/2011 | US8071730 Anti-JAM-A antibodies |
| 12/06/2011 | US8071729 Anti-integrin antibodies, compositions, methods and uses |
| 12/06/2011 | US8071536 Mutant DNA polymerases with improved pyrophosphorolysis activated polymerization (PAP) ability |
| 12/06/2011 | US8071372 Tumor endothelial marker 5α molecules and uses thereof |
| 12/06/2011 | US8071371 Monoclonal antibody production by EBV transformation of B cells |
| 12/06/2011 | US8071348 Replacing aspartate and glutamine residues with alanine causes reduction in catalytic rate and increases substrate binding affinity; kits; drug screening |
| 12/06/2011 | US8071333 Anti-integrin antibodies, compositions, methods and uses |
| 12/06/2011 | US8071323 Human monoclonal antibodies that bind human insulin like growth factors and their use |
| 12/06/2011 | US8071321 administering interferon-beta (IFN- beta) receptor agonist and tumor associated antigen to increase an immune response against the tumor cells |
| 12/06/2011 | US8071111 Virulence of Streptococci |
| 12/06/2011 | US8071104 Neovascular-targeted immunoconjugates |
| 12/06/2011 | US8071103 Pharmaceutical composition comprising a human GLP-1 mimetibody |
| 12/06/2011 | US8071102 Methods to clear meningitis causing agents using antibodies to peptides representing epitopic sites for bacterial and viral meningitis causing agents |
| 12/06/2011 | US8071099 Anti-FLT3 antibodies |
| 12/06/2011 | US8071096 Anti-C5aR antibodies and uses thereof |
| 12/06/2011 | US8071093 Fully human anti-epidermal growth factor receptor antibodies |
| 12/06/2011 | US8071092 Methods of inhibiting B lymphocytes using antibodies to Neutrokine-alpha |
| 12/06/2011 | US8071072 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 12/06/2011 | CA2518548C Peptide fragment of lyve-1 and antibody against the same |
| 12/06/2011 | CA2512933C A pharmaceutical composition comprising an immunoglobulin fc region as a carrier |
| 12/06/2011 | CA2490693C Gene regulation in transgenic animals using a transposon-based vector |
| 12/06/2011 | CA2486759C Universal chimera bank |
| 12/06/2011 | CA2478122C Use of nucloeoside derivatives comprising a citrate group for producing antibodies having affinity for triphosphorylated nucleosides anduses thereof |
| 12/06/2011 | CA2473163C Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies |
| 12/06/2011 | CA2370867C Use of glucose-6-phosphate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
| 12/06/2011 | CA2328783C Human procalcitonin and the preparation and use thereof |
| 12/06/2011 | CA2250164C Oncofetal antigen specific t-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific cd4, cd8 cytotoxic and suppressor t cells and interleukin-10 |
| 12/06/2011 | CA2186573C Sh2-containing inositol-phosphatase |
| 12/01/2011 | WO2011150133A2 Fibronectin based scaffold proteins having improved stability |
| 12/01/2011 | WO2011150086A2 Diagnosis and treatment of autoimmune disease |
| 12/01/2011 | WO2011150008A1 Antibodies to human gdf8 |
| 12/01/2011 | WO2011149909A2 Class i mhc phosphopeptides for cancer immunotherapy and diagnosis |
| 12/01/2011 | WO2011149493A1 Single -chain variable fragment anti-cd133 antibodies and uses thereof |
| 12/01/2011 | WO2011149472A1 Method for preparing an enriched igg composition from plasma |
| 12/01/2011 | WO2011149461A1 Anti-amyloid beta antibodies conjugated to sialic acid-containing molecules |
| 12/01/2011 | WO2011149419A1 Vaccine against streptococcal infections based on recombinant proteins |
| 12/01/2011 | WO2011149402A2 Prostate cancer biomarkers |
| 12/01/2011 | WO2011149099A1 Antigen peptide and use thereof |
| 12/01/2011 | WO2011148952A1 Iga-binding peptide and iga purification using same |
| 12/01/2011 | WO2011147986A1 Monoclonal antibodies against her2 |
| 12/01/2011 | WO2011147984A1 Anti-cd160 specific antibodies for the treatment of eye disorders based on neoangiogenesis |
| 12/01/2011 | WO2011147834A1 Antibodies against cd19 and uses thereof |
| 12/01/2011 | WO2011123489A3 Anti-cd40 antibodies |
| 12/01/2011 | WO2011121556A3 Monoclonal antibody directed against the p17 protein of hiv, capable of neutralising the binding of p17 to the p17 receptor (p17r) |
| 12/01/2011 | WO2011112953A3 Use of erbb3 inhibitors in the treatment of triple negative and basal-like breast cancers |
| 12/01/2011 | WO2011111007A3 ANTIBODIES WITH pH DEPENDENT ANTIGEN BINDING |
| 12/01/2011 | WO2011104604A3 Anti-alpha2 integrin antibodies and their uses |
| 12/01/2011 | WO2011091078A3 Antibody fc variants with enhanced complement activity |
| 12/01/2011 | WO2011086143A3 Liver targeting domain antibodies |
| 12/01/2011 | WO2011034604A3 Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof |
| 12/01/2011 | US20110296546 Human CTLA-4 Antibodies And Their Uses |
| 12/01/2011 | US20110296545 Compositions and methods for treating or preventing conditions and diseases associated with mannheimia haemolytica |
| 12/01/2011 | US20110296544 Colon cancer targets and uses thereof |
| 12/01/2011 | US20110294986 Methods For Detecting Th1 Cells |
| 12/01/2011 | US20110294985 Remedy for Chronic Inflammation and Antibody to be Used Therein |
| 12/01/2011 | US20110294984 Glycosylation Engineering of Antibodies for Improving Antibody-Dependent Cellular Cytotoxicity |
| 12/01/2011 | US20110294952 Optimized Drug Conjugates |
| 12/01/2011 | US20110294865 Methods of detecting a fragment of neurosecretory protein vgf for diagnosing alzheimer's disease |
| 12/01/2011 | US20110294226 Survival motor Neurons (SMN) gene: a gene for spinal muscular atrophy |
| 12/01/2011 | US20110294188 Ideotypically Modulated Pharmacoeffectors For Selective Cell Treatment |
| 12/01/2011 | US20110294162 B-7 related nucleic acids and polypeptides useful for immunomodulation |
| 12/01/2011 | US20110294146 Identification of Actinobacillus actinomycetemcomitans Antigens for Use in the Diagnosis, Treatment, and Monitoring of Periodontal Diseases |
| 12/01/2011 | US20110294145 Reagents and methods for detecting a polymorphic protein |
| 12/01/2011 | US20110294123 Methods for diagnosing or treating prostate cancer |
| 12/01/2011 | US20110294118 Water soluble fluorescent compounds |
| 12/01/2011 | US20110293634 Antibodies binding to adrenomedullin receptors and uses thereof as drugs |